Using incentives to improve care for opioid use disorder
Official title: Incentivized Collaborative Care to Desseminate Contingency Management
Funded at Dynamicare Health, INC. · NIH-10865024 · Data updated 2026-11-12
This study is testing a new digital program that helps people with opioid use disorder by making it easier for them to stick to their treatment plans and get support from their healthcare providers, so they can have a better chance at recovery.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dynamicare Health, INC. NIH-funded |
| Lab location | 1 site (Boston, UNITED STATES) |
| Project start | September 30, 2021 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $894,852 |
| NIH project number | 5R44DA055396-03 |
| Project ID | NIH-10865024 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with opioid use disorder who are seeking treatment with buprenorphine.
✕Less likely to help
Patients who are not diagnosed with opioid use disorder or those who are not interested in pharmacotherapy options may not benefit from this research.
What this research studies
This research investigates a new approach to enhance the delivery of contingency management, an effective incentive-based intervention for individuals with opioid use disorder. It focuses on developing a digital health program that automates the collection of relevant data and the implementation of contingency management procedures. By incentivizing healthcare providers to engage patients and facilitate their enrollment in this program, the research aims to overcome barriers to accessing buprenorphine pharmacotherapy. Patients will receive support and encouragement to adhere to their treatment plans, ultimately improving their chances of recovery.
Why it matters
Potential benefit: If successful, this research could significantly improve treatment outcomes for patients with opioid use disorder by increasing their access to effective care and support.
How similar studies have gone: Previous studies have shown that contingency management is effective in improving treatment adherence and outcomes for patients with opioid use disorder, indicating that this approach has a solid foundation of success.
Where this research is happening
-
Dynamicare Health, INC.
Boston, United States Active
Researchers
- Principal investigator: Gastfriend, David R — Dynamicare Health, INC.
- Study coordinator: Gastfriend, David R
Related research
Other NIH-funded projects on the same topics.
-
Digital treatment that uses contingency management to help people with stimulant use disorder stay abstinent
A digital therapeutic delivered by an app helps people with stimulant use disorder follow a structured program that rewards staying substance-free over a year.
-
At-home app that uses rewards to help people stop stimulant use
An at-home smartphone program offers rewards and self-guided therapy to help people with stimulant use disorder reduce or stop stimulant use.
-
Using a digital app to help treat stimulant use disorder
This study is testing a friendly app that helps people with stimulant use disorder by providing support and rewards for staying drug-free, making it easier for them to stick to their treatment plan.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.